Galafold 123 MG
Ended Awarded
- Contract number
- 36C24525N0795
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,891
Award facts
- Contract value 100% obligated
- $21,891.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a pharmaceutical company focused on rare genetic diseases. The contract is for the supply of the drug Galafold 123 mg, an enzyme replacement therapy used to treat Fabry disease. The contract, valued at $21,891.21, is a task order under the VA's Federal Supply Schedule (FSS) contract 36F79724D0185 for Pharmaceuticals and Drugs (FSS-61-IB), which has a total potential value of $13,024,630 and is valid through August 31, 2029. This contract vehicle allows various VA Veterans Integrated Service Networks (VISNs) to procure specialized pharmaceutical products, ensuring continuous access to critical medications for veterans with Fabry disease. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36C24525N0795?
36C24525N0795 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 9, 2025.
How much is contract 36C24525N0795 worth?
The government has obligated $21,891 on 36C24525N0795.
Is contract 36C24525N0795 an order under another contract?
Yes. 36C24525N0795 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0795 competed?
The extent of competition for 36C24525N0795 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award